These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1357951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Autonomic effects of antiarrhythmic drugs and their importance.
    Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Cappiello E.
    Eur Heart J; 1992 Nov; 13 Suppl F():38-43. PubMed ID: 1282464
    [No Abstract] [Full Text] [Related]

  • 3. Experimental evidence for beta adrenergic blocking properties of propafenone and for their potential clinical relevance.
    Malfatto G, Pessano P, Zaza A, Schwartz PJ.
    Eur Heart J; 1993 Sep; 14(9):1253-7. PubMed ID: 7901020
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.
    Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJ, Roden DM, Woosley RL.
    N Engl J Med; 1990 Jun 21; 322(25):1764-8. PubMed ID: 1971708
    [Abstract] [Full Text] [Related]

  • 6. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM, Palmer KJ, Langtry HD, Fitton A.
    Drugs; 1993 Jan 21; 45(1):85-130. PubMed ID: 7680987
    [Abstract] [Full Text] [Related]

  • 7. An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.
    Kroemer HK, Fromm MF, Bühl K, Terefe H, Blaschke G, Eichelbaum M.
    Circulation; 1994 May 21; 89(5):2396-400. PubMed ID: 7910120
    [Abstract] [Full Text] [Related]

  • 8. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS, Camm AJ.
    Eur J Clin Pharmacol; 1996 May 21; 51(3-4):199-208. PubMed ID: 9010685
    [Abstract] [Full Text] [Related]

  • 9. Spectral analysis of short term R-Tapex interval variability during sinus rhythm and fixed atrial rate.
    Lombardi F, Sandrone G, Porta A, Torzillo D, Terranova G, Baselli G, Cerutti S, Malliani A.
    Eur Heart J; 1996 May 21; 17(5):769-78. PubMed ID: 8737109
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of propafenone on pacing-induced ventricular fibrillation and intracellular calcium in rat hearts.
    Stefenelli T, Wu ST, Parmley WW, Wikman-Coffelt J.
    Eur Heart J; 1992 Nov 21; 13(11):1556-61. PubMed ID: 1334467
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M.
    Eur Heart J; 1994 Aug 21; 15(8):1050-6. PubMed ID: 7527342
    [Abstract] [Full Text] [Related]

  • 14. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 21; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 15. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity.
    Houle MS, Billman GE.
    Am J Physiol; 1999 Jan 21; 276(1):H215-23. PubMed ID: 9887035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV, Nedostup AV.
    Ter Arkh; 2006 Jan 21; 78(8):30-8. PubMed ID: 17078214
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
    Capucci A, Boriani G.
    Drug Saf; 1995 Jan 21; 12(1):55-72. PubMed ID: 7741984
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA, Stiles GL, Shand DG.
    J Pharmacol Exp Ther; 1984 Feb 21; 228(2):461-6. PubMed ID: 6141285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.